E-ISSN 3041-4377
 
2025, Vol: 2, Issue: 2
2 / 2Current Issue ArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles

Original Article
Online Published: 15 Mar 2025
 


Harnessing Ethnomedicinal Knowledge of Narmada Valley Tribes in Central India for Opioid Receptor Targeting in Cancer Palliative Care Management

Mohammad Nadeem Khan, Mahek Bhandari, Sanjay Vyas, Sushil Kumar Upadhyay, Praveen Chandra Dubey.


Abstract
Background: Cancer pain remains a significant challenge in palliative care, often necessitating opioid use despite risks of addiction and adverse effects. Leveraging ethnomedicinal knowledge, this study explores the therapeutic potential of Mitragyna speciosa and Garua pinata derivatives as opioid receptor-targeted therapies for cancer pain management. The study aims to identify bioactive compounds with strong binding affinities to opioid receptors, evaluate their pharmacokinetics, and compare their safety and efficacy to conventional opioids.
Methods: An In-silico approach was employed to investigate the binding affinities of bioactive compounds, including Mitragynine, 7-Hydroxymitragynine, and 6-Hydroxygaruanin-V, to mu (μ), kappa (κ), and delta (δ) opioid receptors. Binding stability was assessed through RMSD analysis, while pharmacokinetic parameters, including molecular weight, ADMET properties, and toxicity, were analyzed to predict drug-likeness and safety.
Results: Docking simulations revealed that Mitragynine, 7-Hydroxymitragynine, and 6-Hydroxygaruanin-V exhibit high binding affinities toward opioid receptors. Notably, 7-Hydroxymitragynine demonstrated a binding affinity to the muopioid receptor comparable to morphine. The compounds exhibited favorable pharmacokinetic profiles, low predicted toxicity, and potential for enhanced receptor interactions through redox-driven mechanisms.
Conclusion: Mitragyna speciosa and Garua pinata derivatives exhibit strong potential as opioid receptor-targeted therapies for cancer palliative care. With promising receptor-binding profiles, superior pharmacokinetics, and low toxicity, these compounds may serve as safer alternatives to traditional opioids. Further in-vitro and in-vivo studies are warranted to validate their clinical efficacy for cancer pain relief.

Key words: Ethnomedicine, phytochemicals, molecular docking, protein interaction, opioid receptor


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Mohammad Nadeem Khan
Articles by Mahek Bhandari
Articles by Sanjay Vyas
Articles by Sushil Kumar Upadhyay
Articles by Praveen Chandra Dubey
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Khan MN, Bhandari M, Vyas S, Upadhyay SK, Dubey PC. Harnessing Ethnomedicinal Knowledge of Narmada Valley Tribes in Central India for Opioid Receptor Targeting in Cancer Palliative Care Management. J Cancer Res Rev. 2025; 2(2): 57-74. doi:10.5455/JCRR.1732704970

Web Style

Khan MN, Bhandari M, Vyas S, Upadhyay SK, Dubey PC. Harnessing Ethnomedicinal Knowledge of Narmada Valley Tribes in Central India for Opioid Receptor Targeting in Cancer Palliative Care Management. https://www.wisdomgale.com/jcrr/?mno=302657762 [Access: March 20, 2025]. doi:10.5455/JCRR.1732704970

AMA (American Medical Association) Style

Khan MN, Bhandari M, Vyas S, Upadhyay SK, Dubey PC. Harnessing Ethnomedicinal Knowledge of Narmada Valley Tribes in Central India for Opioid Receptor Targeting in Cancer Palliative Care Management. J Cancer Res Rev. 2025; 2(2): 57-74. doi:10.5455/JCRR.1732704970


Vancouver/ICMJE Style

Khan MN, Bhandari M, Vyas S, Upadhyay SK, Dubey PC. Harnessing Ethnomedicinal Knowledge of Narmada Valley Tribes in Central India for Opioid Receptor Targeting in Cancer Palliative Care Management. J Cancer Res Rev. (2025), [cited March 20, 2025]; 2(2): 57-74. doi:10.5455/JCRR.1732704970


Harvard Style

Khan, M. N., Bhandari, . M., Vyas, . S., Upadhyay, . S. K. & Dubey, . P. C. (2025) Harnessing Ethnomedicinal Knowledge of Narmada Valley Tribes in Central India for Opioid Receptor Targeting in Cancer Palliative Care Management. J Cancer Res Rev, 2 (2), 57-74. doi:10.5455/JCRR.1732704970


Turabian Style

Khan, Mohammad Nadeem, Mahek Bhandari, Sanjay Vyas, Sushil Kumar Upadhyay, and Praveen Chandra Dubey. 2025. Harnessing Ethnomedicinal Knowledge of Narmada Valley Tribes in Central India for Opioid Receptor Targeting in Cancer Palliative Care Management. Journal of Cancer Research and Reviews, 2 (2), 57-74. doi:10.5455/JCRR.1732704970


Chicago Style

Khan, Mohammad Nadeem, Mahek Bhandari, Sanjay Vyas, Sushil Kumar Upadhyay, and Praveen Chandra Dubey. "Harnessing Ethnomedicinal Knowledge of Narmada Valley Tribes in Central India for Opioid Receptor Targeting in Cancer Palliative Care Management." Journal of Cancer Research and Reviews 2 (2025), 57-74. doi:10.5455/JCRR.1732704970


MLA (The Modern Language Association) Style

Khan, Mohammad Nadeem, Mahek Bhandari, Sanjay Vyas, Sushil Kumar Upadhyay, and Praveen Chandra Dubey. "Harnessing Ethnomedicinal Knowledge of Narmada Valley Tribes in Central India for Opioid Receptor Targeting in Cancer Palliative Care Management." Journal of Cancer Research and Reviews 2.2 (2025), 57-74. Print. doi:10.5455/JCRR.1732704970


APA (American Psychological Association) Style

Khan, M. N., Bhandari, . M., Vyas, . S., Upadhyay, . S. K. & Dubey, . P. C. (2025) Harnessing Ethnomedicinal Knowledge of Narmada Valley Tribes in Central India for Opioid Receptor Targeting in Cancer Palliative Care Management. Journal of Cancer Research and Reviews, 2 (2), 57-74. doi:10.5455/JCRR.1732704970


Author LoginReviewer LoginAbout PublisherOpen Access PolicyEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesTerms of UseLicense InformationCopyright Information

About Journal of Cancer Research and Reviews

Journal of Cancer Research and Reviews is an international journal that considers full-length articles in the broad area of basic, clinical and translatio ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information

Your comments are very important to us

We welcome your ideas, suggestions, comments, or questions. To reach Editorial Board please use one of the methods provided below.
 

Emails:

info@wisdomgale.com
editorinchief@ejmanager.com

Office Address:
WisdomGale Publishing
14 Rue de Grand-Bigard,
1082 Brussels
Belgium
 
We will respond within 48 to 72 hours.
 
Change of address or personal information? Please visit your account at www.ejmanager.com to update your information.